Jennifer Kayden Lee
EVP, Head of North America · 3 filings · Latest: Aug 13, 2026
RHYTHM PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RYTM | Jennifer Kayden Lee | EVP, Head of North America | Aug 13, 2026 | Sale | $117.38 | 75,834 | $8.9M | 0 | |
RYTM | Jennifer Kayden Lee | EVP, Head of North America | Aug 13, 2026 | Option Exercise | $17.62 | 56,601 | $997.0K | 75,834 | |
RYTM | Jennifer Kayden Lee | — | Aug 13, 2026 | Proposed Sale | $117.60 | 75,834 | $8.9M | — | |
RYTM | Jennifer Kayden Lee | EVP, Head of North America | Feb 1, 2026 | Option Exercise | — | 22,612 | — | 28,470 | |
RYTM | JENNIFER KAYDEN LEE | — | Feb 13, 2025 | Proposed Sale | $57.64 | 1,205 | $69.5K | — | |
RYTM | JENNIFER KAYDEN LEE | — | Feb 12, 2025 | Proposed Sale | $57.58 | 1,205 | $69.4K | — | |
RYTM | JENNIFER KAYDEN LEE | — | Feb 10, 2025 | Proposed Sale | $59.18 | 4,189 | $247.9K | — | |
RYTM | JENNIFER KAYDEN LEE | — | Feb 5, 2025 | Proposed Sale | $59.95 | 3,066 | $183.8K | — | |
RYTM | JENNIFER KAYDEN LEE | — | Nov 11, 2024 | Proposed Sale | $67.33 | 66,861 | $4.5M | — |